Highly active anti retroviral therapy including nevirapine once daily versus twice daily after at least 12 weeks of nevirapine twice daily. A randomized, open, multicentre trial
Phase of Trial: Phase III
Latest Information Update: 01 Apr 2009
At a glance
- Drugs Nevirapine (Primary)
- Indications HIV infections; HIV-1 infections
- Focus Adverse reactions; Therapeutic Use
- Acronyms NODy
- 01 Apr 2009 Results published in the Journal of Acquired Immune Deficiency Syndromes.
- 03 Nov 2006 New trial record.